197 results on '"Pipitone, Rosaria Maria"'
Search Results
2. SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease
3. The PD-1/PD-L1 Axis in the Biology of MASLD
4. PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease
5. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease
6. Corrigendum to “SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease” [J Hepatol 80 (2024) 10-19]
7. Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin‐22, interleukin‐6 and interleukin‐1Ra concentrations according to portal hypertension and disease severity
8. SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease
9. Red and golden tomato administration improves fat diet-induced hepatic steatosis in rats by modulating HNF4α, Lepr, and GK expression
10. Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis
11. Programmed cell death 1 genetic variant and liver damage in non-alcoholic fatty liver disease
12. Red and Golden Tomato Administration Improves Fat Di-Et-Induced Hepatic Steatosis in Rats by Modulating HNF4, Lepr and GK Expression
13. Metabolic Memory in Diabetic Foot Syndrome (DFS): Epigenetic Changes of the Expression of Micro-rnas and Single Nucleotide Polymorphisms (SNPS) Frequency in a Cohort of Diabetic Patients With and Without Foot Ulceration and Correlation With Indices of Endothelial and Adipo-inflammatory Dysfunction
14. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease
15. Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation
16. Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line
17. MAFLD: a multisystem disease
18. Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development
19. Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease
20. SIRT5 rs12216101 T > G variant is associated with mitochondrial dysfunction and disease severity in patients with NAFLD
21. A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease
22. A cholestatic pattern predicts major liver‐related outcomes in patients with non‐alcoholic fatty liver disease
23. A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease
24. 3-Aryl-2-[1 H-benzotriazol-1-yl]acrylonitriles: A novel class of potent tubulin inhibitors
25. Synthesis, antiproliferative activity, and mechanism of action of a series of 2-{[(2 E)-3-phenylprop-2-enoyl]amino}benzamides
26. Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activity
27. Correction to "Novel Antiproliferative Chimeric Compounds with Marked Histone Deacetylase Inhibitory Activity".
28. The Antineoplastic Role of STAT5 Inhibition in BCRABL1-Positive Cells Exposed to Pimozide Alone and in Combination with Dasatinib and Ponatinib
29. NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease
30. PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19
31. Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease
32. WED-549 - Programmed cell death 1 genetic variant and liver damage in non-alcoholic fatty liver disease
33. A Cholestatic Pattern Predicts Liver-Related Events in Patients with Nonalcoholic Fatty Liver Disease
34. Insulin-Like Growth Factor-I, Inflammatory Proteins, and Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease
35. Dehydrocholesterol Reductase rs12785878 G/T Single Nucleotide Polymorphism Affects Liver Fibrosis in Patients with Genotype 1 Chronic Hepatitis C: 939
36. SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study
37. Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis
38. A cholestatic pattern predicts liver outcomes in patients with non-alcoholic fatty liver disease
39. PNPLA3 and TLL-1 polymorphisms affect disease severity in patients with COVID-19
40. PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD
41. GEMS, a Genetic and Metabolic Staging Predicting the Outcome of Non-Alcoholic Fatty Liver Disease
42. NR1H4 rs35724 G>C Variant Modulates Liver Damage in Nonalcoholic Fatty Liver Disease
43. Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.
44. NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients
45. Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease
46. SAT-223-AA genotype of the deSNP rs6726639 of gene MERTK (MER Tyrosine Kinase) is associated with development of hepatocellular carcinoma after hepatitis C virus clearance
47. THU-335-FXR rs35724 C >G variant modulates cholesterol levels, carotid atherosclerosis and liver damage in non-alcoholic fatty liver
48. THU-334-PNPLA3 rs738409 C >G variant predicts liver-related events and death in non-alcoholic fatty liver
49. PNPLA3 Rs738409 C>G Variant Predicts Liver-Related Outcomes in Patients with Non-Alcoholic Fatty Liver Disease
50. Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.